Low-dose pulse cyclophosphamide in the treatment of neuropsychiatric lupus

The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes . Arthritis Rheum 1999; 42: 599-608 .

Ainala H , Loukkola J , Peltola J , Korpela M , Hietaharju A. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus . Neurology 2001; 57: 496-500 .

Ainala H , Hietaharju A , Loukkola J et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation . Arthritis Rheum, 2001; 45: 419-423 .

Mok CC , Lau CS , Wong RW. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus . J Rheumatol 2001; 28: 766-771 .

Brey RL , Holliday SL , Saklad AR et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions . Neurology 2002; 58: 1214-1220 .

Sanna G , Bertolaccini M , Cuadrado M et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies . J Rheumatol 2003; in press.

West SG. Lupus and the central nervous system . Curr Opin Rheumatol 1996; 8: 408-414 .

DeGiorgio LA , Konstantinov KN , Lee SC , Hardin JA , Volpe BT , Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus . Nat Med 2001; 7: 1189-1193 .

Levine SR , Deegan MJ , Futrell N , Welch KM. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases . Neurology 1990; 40: 1181-1189 .

Toubi E , Khamashta MA , Panarra A , Hughes GR. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus . Am J Med 1995; 99: 397-401 .

Denburg SD , Carbotte RM , Ginsberg JS , Densburg JA. The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus . J Int Neuropsychol Soc 1997; 3: 377-386 .

Menon S , Jameson-Shortall E , Newman SP , Hall-Craggs MR , Chinn R , Isenberg DA. A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus . Arthritis Rheum 1999; 42: 735-741 .

Hanly JG , Hong C , Smith S , Fisk JD. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus . Arthritis Rheum 1999: 728-734 .

Denburg SD , Carbotte RM , Denburg JA. Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus . Arthritis Rheum 1994; 37: 1311-1320 .

Neuwelt CM , Lacks S , Kaye BR , Ellman JB , Borenstein DG. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus . Am J Med 1995; 98: 32-41 .

Hughes G. Thrombosis, abortion, cerebral disease and the lupus anticoagulant . BMJ 1983; 287: 1088-1089 .

Khamashta MA , Cuadrado MJ , Mujic F , Taub NA , Hunt BJ , Hughes GR. The management of thrombosis in the antiphospholipid-antibody syndrome . N Engl J Med 1995; 332: 993-997 .

Boumpas DT , Yamada H , Patronas NJ , Scott D , Klippel JH , Balow JE. Pulse cyclophosphamide for severe neuropsychiatric lupus . Q J Med 1991; 81: 975-984 .

Ramos PC , Mendez MJ , Ames PR , Khamashta MA , Hughes GR. Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus . Clin Exp Rheumatol 1996; 14: 295-299 .

Baca V , Lavalle C , Garcia R et al. Favourable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus . J Rheumatol 1999; 26: 432-439 .

Takada K , Illei GG , Boumpas DT. Cyclophosphamide for the treatment of systemic lupus erythematosus . Lupus 2001; 10: 154-161 .

Boumpas DT , Austin HA 3rd , Vaughan EM , Yarboro CH , Klippel JH , Balow JE. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy . Ann Intern Med 1993; 119: 366-369 .

Martin-Suarez I , D’Cruz D , Mansoor M , Fernandes AP , Khamashta MA , Hughes GR. Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide . Ann Rheum Dis 1997; 56: 481-487 .

Stojanovich L , Stojanovich R , Kostich V , Dzjolich E. Neuropsychiatric lupus favorable response to low dose i.v. cyclophosphamide and prednisolone (pilot study) . Lupus 2003; 12: 3-7 .